A Randomised Controlled Trial Investigating a Comparison of Fluoride Varnish vs Self-Etching Dentine Bonding Agent in the Reduction of Cervical Dentine Sensitivity in Patients Attending a General Dental Practice in West Sussex, UK.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Dentin Sensitivity
- Sponsor
- University of Kent
- Enrollment
- 26
- Locations
- 1
- Primary Endpoint
- Visual Analogue Scale
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
This study compares the efficacy of two dental interventions in the treatment of cervical dentine sensitivity. The participants will be selected from adult dental patients registered at a general dental practice in West Sussex, UK. The participants will be split into 2 groups. One group will receive the intervention of topical fluoride varnish application while the other group will receive a topical application of self-etching dentine bonding agent.
Detailed Description
Topical Fluoride Varnish(TFV) and Self-Etching Dentine Bonding Agent (SEDBA) are both routinely used in dentistry in the management of cervical dentine sensitivity(CDS). Both interventions are topically applied and well tolerated by patients. The interventions differ in mechanism of action. TFV releases fluoride which is incorporated into the organic matrix of dentine making the dentine tubules less conductive. Dentinal tubules form the key conduit between stimulus and pain perception in the tooth. SEDBA differs in that it penetrates and occludes the tubules. It is light cured for an almost instant set time.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Exhibiting CDS elicited by the two test stimuli in relation at least one tooth.
Exclusion Criteria
- •Patients who have undergone comprehensive periodontal treatment in the past 3 months.
- •Patients under the age of 18 or unable to provide valid consent.
- •Teeth that have visible fracture lines, caries, crowns or have been endodontically treated.
- •Patients taking analgesic medication for any systemic conditions.
Outcomes
Primary Outcomes
Visual Analogue Scale
Time Frame: 14 days
to measure pain/sensitivity perception